Freightos Reports Third Quarter 2024 Results: Revenue Up 21%, Record Since Going Public
Full-year revenue guidance now at the higher end of the previous range, Adjusted EBITDA guidance up BARCELONA, Spain, Nov. 25, 2024 /PRNewswire/ -- Freightos Limited ...
Northern Superior Resources Inc.: Northern Superior Announces ONGold's Agreements to Acquire Monument Bay and Domain Gold Projects in Manitoba
TORONTO, ON / ACCESSWIRE / November 25, 2024 / Northern Superior Resources Inc. ("Northern Superior") (TSXV:SUP)(OTCQX:NSUPF)(GR:D9M1) is pleased to announce that ONGold Resources Ltd. ("ONGold" or th ...
Global Technologies, Ltd Announces H. "Wyatt" Flippen as Its New Chief Executive Officer
Global Technologies, Ltd (OTC: GTLL), a multi-operational company driving innovation and sustainable growth across the technology and service sectors ...
Seabridge Gold Inc.: Seabridge's KSM Project Substantially Started Determination Challenged by Tsetsaut Skii km Lax Ha
Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) ("Seabridge" or the "Company") announced today that the Tsetsaut Skii km Lax Ha ("TSKLH") has filed a ...
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
Amglidia® has been approved by the European Medicines Agency (EMA) and is commercially available in EuropeStrong strategic fit with Eton's existing pediatric endocrinology focusAmglidia has been grant ...
U-BX Technology Ltd. Announces Effective Date of Reverse Stock Split
U-BX Technology Ltd. (the "Company" or "U-BX") (NASDAQ:UBXG), a leading company providing value-added services using artificial intelligence-driven technology ...
Alarum Technologies Ltd.: Alarum Technologies Announces Third Quarter 2024 Results
Achieves quarterly revenues of $7.2 million at top-end of guidance, record net profit of $4.2 million and Adjusted EBITDA outperformed guidance at $1.4 million; strong cash generation and $24.0 millio ...
TransCode Therapeutics, Inc.: TransCode Therapeutics Announces 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA ...
Global Crossing Airlines Group Inc.: Global Crossing Airlines Announces Annual Meeting Results
Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) (the "Company" or "GlobalX"), the Nation's fastest growing charter airline, ...
Cenovus Energy Inc.: Cenovus Energy announces redemption of Series 3 Preferred Shares
Cenovus Energy Inc. ("Cenovus" or the "Company") (TSX: CVE) (NYSE: CVE) announced today it will exercise its right to redeem the Company's 4.689% Series ...
NOA Lithium Brines Inc.: NOA Lithium Announces Brine Processing Results
BUENOS AIRES, ARGENTINA / ACCESSWIRE / November 25, 2024 / NOA Lithium Brines Inc. (TSX-V:NOAL)(FSE:N7N) (" NOA " or the " Company ") is pleased to provide an update on the significant progress of its ...
Cassava Sciences, Inc.: Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints
Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's disease in the ReThink-ALZ Phase 3 study Simufilam contin ...